Рубрики Mesh:
Биомаркеры новообразований - биосинтез
Карцинома переходно-клеточная - метаболизм
Карцинома переходно-клеточная - патология
Человек
Иммуногистохимия
Новообразований стволовые клетки - метаболизм
Новообразований стволовые клетки - патология
Прогноз
Мочевой системы новообразования - метаболизм
Мочевой системы новообразования - патология
Эпителий мочевой системы - метаболизм
Эпителий мочевой системы - патология
Журнальная статья
Osmanov Y.I. Yu I
Kogan E.A.
Rapoport L.M.
Teodorovich O.V.
Gaibov J.A.
) Department of Pathology of I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
) Department of Urology of GBOU I.M. Sechenov First Moscow State Medical University, Moscow, Russia.
) Department of endoscopic urology of NUZ NKC OAO RJD, FGBOU DPO RMANPO, Moscow, Russia.
) Department of Pathology of Scientific Clinical Center of Russian Railways, Moscow, Russia.
Markers of stem cells and their prognostic values for urothelial carcinomas of the urinary tract
Текст визуальный электронный
Urologiia (Moscow, Russia : 1999)
№ 2 С. 40-49
2019
cancer stem cells
intratumoral heterogeneity
urothelial carcinoma
Статья
Biomarkers, Tumor biosynthesis D23.101.140
Биомаркеры новообразований биосинтез D23.101.140
Carcinoma, Transitional Cell metabolism C04.557.470.200.430
Carcinoma, Transitional Cell pathology C04.557.470.200.430
Карцинома переходно-клеточная метаболизм C04.557.470.200.430
Карцинома переходно-клеточная патология C04.557.470.200.430
Humans B01.050.150.900.649.313.988.400.112.400.400
Человек B01.050.150.900.649.313.988.400.112.400.400
Immunohistochemistry E01.370.225.500.607.512 E01.370.225.750.551.512 E05.200.500.607.512 E05.200.750.551.512 E05.478.583 H01.158.100.656.234.512 H01.158.201.344.512 H01.158.201.486.512 H01.181.122.573.512 H01.181.122.605.512
Иммуногистохимия E01.370.225.500.607.512 E01.370.225.750.551.512 E05.200.500.607.512 E05.200.750.551.512 E05.478.583 H01.158.100.656.234.512 H01.158.201.344.512 H01.158.201.486.512 H01.181.122.573.512 H01.181.122.605.512
Neoplastic Stem Cells metabolism A11.872.650
Neoplastic Stem Cells pathology A11.872.650
Новообразований стволовые клетки метаболизм A11.872.650
Новообразований стволовые клетки патология A11.872.650
Prognosis E01.789
Прогноз E01.789
Urologic Neoplasms metabolism C04.588.945.947 C12.050.351.937.820 C12.200.758.820 C12.900.820 C12.950.983
Urologic Neoplasms pathology C04.588.945.947 C12.050.351.937.820 C12.200.758.820 C12.900.820 C12.950.983
Мочевой системы новообразования метаболизм C04.588.945.947 C12.050.351.937.820 C12.200.758.820 C12.900.820 C12.950.983
Мочевой системы новообразования патология C04.588.945.947 C12.050.351.937.820 C12.200.758.820 C12.900.820 C12.950.983
Urothelium metabolism A10.272.850
Urothelium pathology A10.272.850
Эпителий мочевой системы метаболизм A10.272.850
Эпителий мочевой системы патология A10.272.850
Journal Article V02.600
Журнальная статья V02.600
The fundamental question about the origin of cancer stem cells of urothelial carcinomas with luminal remains open. So far, no convincing evidence has been found to determine whether these events occur in a single cell, presumably basal, or are realized in different precursor cells of the urothelium. The potential of a number of potential stem markers as cancer stem cells in urothelial carcinomas and their prognostic significance are currently being investigated.